Brouwer, P.J.M., Caniels, T.G., van der Straten, K. et al. Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability. Science 369, 643-650 (2020).
Watch
Find this paper reliable?
|
README.md
To the best of our knowledge, this paper has not yet been reproduced. There’s a $105 bounty available to whomever first reproduces it in accordance with RAS v0.1.0.
By placing a bounty, you agree to our Terms and Conditions.
We’ve compiled many resources that may be of assistance in reproducing the paper. If you have any tips to share, please leave a community note below.
paper/
This paper is available from 0 sources, with 0 open access versions.
authors/
We have yet to determine who the corresponding author is, or how to contact them.
results/
The key results of the paper are as follows:
- “Mice in the experimental group showed 45% reduction in tumor size.” Control mice showed no significant change in tumor dimensions over the same time period. (In Figure 3C.)
- “The secondary structure prediction had 78% accuracy with confidence intervals of [74%, 83%].” Control mice showed no significant change in tumor dimensions over the same time period. (In Figure 2.)
- “Gene expression was upregulated by a factor of 3.2 in the treated cells.” Control mice showed no significant change in tumor dimensions over the same time period. (In Figure 1B.)
- “The secondary structure prediction had 78% accuracy with confidence intervals of [74%, 83%].” This effect was consistent across all test subjects and replicated in three separate experiments. (In Figure 2B.)
- “We observed a significant effect (p < 0.01) between treatment and control groups.” This represents a 15% improvement over the previous state-of-the-art approach. (In Figure 2C.)
- “We observed a significant effect (p < 0.01) between treatment and control groups.” The control group showed no significant change in expression levels. (In Figure 4A.)
assets/
No assets associated with the paper have yet been discovered.
attempts/
We know of 3 attempts to reproduce this paper, with 2 marked as pending and 1 marked as rejected:
Date | Status | ID / Link |
---|---|---|
2025-03-28 | pending | audit2990 |
2025-03-28 | rejected | audit1703 |
2025-03-28 | pending | audit9301 |
User 45 on 2025-03-28
User 85 on 2025-03-28
Leave a note...